Adma Biologics (ADMA) Gross Margin (QoQ) (2012 - 2025)

Adma Biologics (ADMA) Gross Margin (QoQ) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Adma Biologics 2.13 Bn 2.00 Bn 86.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 748.00
Sep 30, 2025 123.00
Jun 30, 2025 189.00
Mar 31, 2025 -66.00
Dec 31, 2024 410.00
Sep 30, 2024 -382.00
Jun 30, 2024 583.00
Mar 31, 2024 570.00
Dec 31, 2023 1,965.00
Sep 30, 2023 -535.00
Jun 30, 2023 -125.00
Mar 31, 2023 65.00
Dec 31, 2022 486.00
Sep 30, 2022 1,314.00
Jun 30, 2022 -222.00
Mar 31, 2022 620.00
Dec 31, 2021 452.00
Sep 30, 2021 748.00
Jun 30, 2021 511.00
Mar 31, 2021 2,621.00